Greenwich LifeSciences, Inc. - stock earnings
GLSI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -2.4 million USD | ? USD |
| 2023Q2 | -1.6 million USD | ? USD |
| 2023Q1 | -2.0 million USD | ? USD |
| 2022Q4 | -2.6 million USD | ? USD |
| 2022Q3 | -2.3 million USD | ? USD |
| 2022Q2 | -718839 USD | ? USD |
| 2022Q1 | -2.0 million USD | ? USD |
| 2021Q4 | -2.4 million USD | ? USD |
| 2021Q3 | -863118 USD | ? USD |
| 2021Q2 | -749745 USD | ? USD |
| 2021Q1 | -597008 USD | ? USD |
| 2020Q4 | -1.2 million USD | ? USD |
| 2020Q3 | -256865 USD | ? USD |
| 2020Q2 | -210430 USD | ? USD |
| 2020Q1 | -244641 USD | ? USD |
| 2019Q4 | -336536 USD | ? USD |
| 2019Q3 | -336013 USD | ? USD |
| 2019Q2 | -2.6 million USD | ? USD |
GLSI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -8.9 million USD | ? USD |
| 2022 | -7.6 million USD | ? USD |
| 2021 | -4.5 million USD | ? USD |
| 2020 | -1.9 million USD | ? USD |
| 2019 | -3.4 million USD | ? USD |
| 2018 | -1.7 million USD | ? USD |
GLSI
Price: $13.12
52 week price:
Earnings Per Share: -0.70 USD
P/E Ratio: -12.07
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 30476
Market Capitalization: 227.7 million